Article

Forbes on 2023-11-09 15:56

AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows

The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.

Pascal Soriot

Related news

Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial Forbes
Europe , Phase 2 , Denmark
FDA approves obesity drug that helped people cut weight 15%Merced Sun-Star
Maryland , Largo , Denmark
Powerful new obesity drug poised to upend weight loss care staradvertiser.com
Brigham City , Indianapolis
New weight loss pill helps shed weight twice as fast as Ozempic New York Post
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous Seattle Times
MLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'4 min read marketwatch.com
Phase 1
Pfizer Pulls Experimental Twice-Daily Weight Loss Drug—Shares Slide 6% To Multiyear Low Forbes
U.S. Will Not Be Paying More Than Other Wealthy Countries For Pfizer’s Covid-19 Pill Forbes
United Kingdom , Japan , Italy , Germany , France
New Vibrating Pill May Be A Cost Effective Option To Aid Weight Loss, Study Finds Forbes
Pill unter dem Bache
FDA approves obesity drug that helped people cut weight 15% - Fri, 04 Jun 2021 PST The Spokesman-Review
Maryland , Largo , Denmark
FDA approves injectable obesity drug that helps people cut weight 15%timesofisrael.com
Maryland , Largo , Denmark , Israel , New York